Literature DB >> 25196814

Muscle MRS detects elevated PDE/ATP ratios prior to fatty infiltration in Becker muscular dystrophy.

B H Wokke1, M T Hooijmans, J C van den Bergen, A G Webb, J J Verschuuren, H E Kan.   

Abstract

Becker muscular dystrophy (BMD) is characterized by progressive muscle weakness. Muscles show structural changes (fatty infiltration, fibrosis) and metabolic changes, both of which can be assessed using MRI and MRS. It is unknown at what stage of the disease process metabolic changes arise and how this might vary for different metabolites. In this study we assessed metabolic changes in skeletal muscles of Becker patients, both with and without fatty infiltration, quantified via Dixon MRI and (31) P MRS. MRI and (31) P MRS scans were obtained from 25 Becker patients and 14 healthy controls using a 7 T MR scanner. Five lower-leg muscles were individually assessed for fat and muscle metabolite levels. In the peroneus, soleus and anterior tibialis muscles with non-increased fat levels, PDE/ATP ratios were higher (P < 0.02) compared with controls, whereas in all muscles with increased fat levels PDE/ATP ratios were higher compared with healthy controls (P ≤ 0.05). The Pi /ATP ratio in the peroneus muscles was higher in muscles with increased fat fractions (P = 0.005), and the PCr/ATP ratio was lower in the anterior tibialis muscles with increased fat fractions (P = 0.005). There were no other significant changes in metabolites, but an increase in tissue pH was found in all muscles of the total group of BMD patients in comparison with healthy controls (P < 0.05). These findings suggest that (31) P MRS can be used to detect early changes in individual muscles of BMD patients, which are present before the onset of fatty infiltration.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Becker muscular dystrophy; MRS; PDE; phosphor spectroscopy

Mesh:

Substances:

Year:  2014        PMID: 25196814     DOI: 10.1002/nbm.3199

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  16 in total

Review 1.  Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials.

Authors:  Pierre G Carlier; Benjamin Marty; Olivier Scheidegger; Paulo Loureiro de Sousa; Pierre-Yves Baudin; Eduard Snezhko; Dmitry Vlodavets
Journal:  J Neuromuscul Dis       Date:  2016-03-03

Review 2.  Advancements in magnetic resonance imaging-based biomarkers for muscular dystrophy.

Authors:  Doris G Leung
Journal:  Muscle Nerve       Date:  2019-05-14       Impact factor: 3.217

3.  Relationship between markers of disease activity and progression in skeletal muscle of GNE myopathy patients using quantitative nuclear magnetic resonance imaging and 31P nuclear magnetic resonance spectroscopy.

Authors:  Harmen Reyngoudt; Benjamin Marty; Ericky Caldas de Almeida Araújo; Pierre-Yves Baudin; Julien Le Louër; Jean-Marc Boisserie; Anthony Béhin; Laurent Servais; Teresa Gidaro; Pierre G Carlier
Journal:  Quant Imaging Med Surg       Date:  2020-07

4.  Evaluation of skeletal muscle DTI in patients with duchenne muscular dystrophy.

Authors:  M T Hooijmans; B M Damon; M Froeling; M J Versluis; J Burakiewicz; J J G M Verschuuren; E H Niks; A G Webb; H E Kan
Journal:  NMR Biomed       Date:  2015-10-09       Impact factor: 4.044

5.  Baseline fat fraction is a strong predictor of disease progression in Becker muscular dystrophy.

Authors:  Thom T J Veeger; Nienke M van de Velde; Kevin R Keene; Erik H Niks; Melissa T Hooijmans; Andrew G Webb; Jurriaan H de Groot; Hermien E Kan
Journal:  NMR Biomed       Date:  2022-02-05       Impact factor: 4.478

Review 6.  In-vivo31P-MRS of skeletal muscle and liver: A way for non-invasive assessment of their metabolism.

Authors:  Ladislav Valkovič; Marek Chmelík; Martin Krššák
Journal:  Anal Biochem       Date:  2017-01-21       Impact factor: 3.365

Review 7.  Quantifying fat replacement of muscle by quantitative MRI in muscular dystrophy.

Authors:  Jedrzej Burakiewicz; Christopher D J Sinclair; Dirk Fischer; Glenn A Walter; Hermien E Kan; Kieren G Hollingsworth
Journal:  J Neurol       Date:  2017-07-01       Impact factor: 4.849

8.  Skeletal muscle alkaline Pi pool is decreased in overweight-to-obese sedentary subjects and relates to mitochondrial capacity and phosphodiester content.

Authors:  Ladislav Valkovič; Marek Chmelík; Barbara Ukropcová; Thomas Heckmann; Wolfgang Bogner; Ivan Frollo; Harald Tschan; Michael Krebs; Norbert Bachl; Jozef Ukropec; Siegfried Trattnig; Martin Krššák
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

9.  13C/31P MRS Metabolic Biomarkers of Disease Progression and Response to AAV Delivery of hGAA in a Mouse Model of Pompe Disease.

Authors:  Celine Baligand; Adrian G Todd; Brittany Lee-McMullen; Ravneet S Vohra; Barry J Byrne; Darin J Falk; Glenn A Walter
Journal:  Mol Ther Methods Clin Dev       Date:  2017-09-08       Impact factor: 6.698

10.  Spatially localized phosphorous metabolism of skeletal muscle in Duchenne muscular dystrophy patients: 24-month follow-up.

Authors:  M T Hooijmans; N Doorenweerd; C Baligand; J J G M Verschuuren; I Ronen; E H Niks; A G Webb; H E Kan
Journal:  PLoS One       Date:  2017-08-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.